DEVELOPMENT AND EVALUATION OF A NOVEL PELLETS BASED TABLET SYSTEM OF PANTOPRAZOLE
*Jayesh Kapadiya
ABSTRACT
Objective: Peptic ulcer refers to the ulceration in the gastric
environment. Pantoprazole is the class of drug that is used in the ulcer
treatment. For better patient compliance and to deliver drug safely
pellets containing dosage form are now in demand. Multiple unit pellet
system (MUPS) is such a dosage form to deliver drug locally and faster
in action. Experimental work: Delayed release formulation was
designed to trial and error method in which various trials are taken and
optimization of coating agent and cushioning agent was being carried
out. Pantoprazole pellets were prepared by extrusion-spheronization method. Pantoprazole
belongs to the class of proton pump inhibitors that required gastric protection. Cellulose
acetate phthalate was used for enteric coating of pellets. Enteric coated pellets were then
compressed along with cushioning agent (MCC PH 101) and evaluated for their acid
resistance and % drug release. A 32 factorial design was used for optimization by taking
concentration of coating solution (X1) and concentration of MCC PH 101 as independent
variables and the % drug release at 6 hr (Y1) as dependent variables. Result: The moderate
concentration of coating solution and MCC PH 101 provides desired acid resistance and
release of pantoprazole. Batch F9 was considered optimum because it has maximum acid
resistance and desired drug release. Conclusion: Gastro-resistant MUPS dosage form has
been successfully developed for pantoprazole using 8 % concentration of Cellulose acetate
phthalate (as a coating agent) and 75 % concentration of MCC PH 101 (as a cushioning
agent).
Keywords: Gastro-resistant, Delayed release, Multiple unit pellet system, Cellulose acetate phthalate, MCC PH 101.
[Download Article]
[Download Certifiate]